Detection of MicroRNAs in Archival Cytology Urine Smears

PLoS ONE

Volumn 8, Issue 2, 2013, Pages

  Simonato, Francesca ^a   Ventura, Laura ^a   Sartori, Nicola ^a   Cappellesso, Rocco ^a   Fassan, Matteo ^b   Busund, Lill Tove ^c   Fassina, Ambrogio ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b UNIVERSITY OF VERONA   (Italy)

^c UNIVERSITY HOSPITAL OF NORTH NORWAY   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; MICRORNA 145; MICRORNA 205;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; DOWN REGULATION; ERYTHROCYTE COUNT; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; INFLAMMATORY CELL; MALE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS; ROOM TEMPERATURE; STORAGE TEMPERATURE; TRANSITIONAL CELL CARCINOMA; URINALYSIS; URINE CYTOLOGY;

FEASIBILITY STUDIES; HUMANS; MICRORNAS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 84874572440     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0057490     Document Type: Article

References (34)

1. Witjes JA, Hendricksen K, (2008) Intravesical pharmacotherapy for non-muscle-invasive bladder cancer: a critical analysis of currently available drugs, treatment schedules, and long-term results. Eur Urol 53: 45-52.
2. Eble JN. (2004) Pathology and genetics of tumours of the urinary system and male genital organs. Lyon: IARC press.
3. Fassan M, Trabulsi EJ, Gomella LG, Baffa R, (2007) Targeted therapies in the management of metastatic bladder cancer. Biologics Dec 1: 393-406.
4. Bastacky S, Ibrahim S, Wilczynski SP, Murphy WM, (1999) The accuracy of urinary cytology in daily practice. Cancer 87: 118-128.
5. Brown FM, (2000) Urine cytology. It is still the gold standard for screening? Urol Clin North Am 27: 25-37.
6. Koss LG, Deitch D, Ramanathan R, Sherman AB, (1985) Diagnostic value of cytology of voided urine. Acta Cytol 29: 810-816.
7. Tilki D, Burger M, Dalbagni G, Grossman HB, Hakenberg OW, et al. (2011) Urine markers for detection and surveillance of non-muscle-invasive bladder cancer. Eur Urol 60: 484-492.
8. Gutierrez Banos JL, del Henar Rebollo Rodrigo M, Antolin Juarez FM, Garcia BM, (2001) Usefulness of the BTA STAT Test for the diagnosis of bladder cancer. Urology 57: 685-689.
9. Hwang EC, Choi HS, Jung SI, Kwon DD, Park K, et al. (2001) Use of the NMP22 BladderChek test in the diagnosis and follow-up of urothelial cancer: a cross-sectional study. Urology 77: 154-159.
10. Daniely M, Rona R, Kaplan T, Olsfanger S, Elboim L, et al. (2007) Combined morphologic and fluorescence in situ hybridization analysis of voided urine samples for the detection and follow-up of bladder cancer in patients with benign urine cytology. Cancer 111: 517-524.
11. Calin GA, Croce CM, (2006) MicroRNA signatures in human cancers. Nat Rev Cancer 6: 857-866.
12. Gottardo F, Liu CG, Ferracin M, Calin GA, Fassan M, et al. (2007) Micro-RNA profiling in kidney and bladder cancers. Urol Oncol 25: 387-392.
13. Fassina A, Cappellesso R, Simonato F, Lanza C, Marzari A, et al. (2012) Fine needle aspiration of non-small cell lung cancer: current state and future perspective. Cytopathology 23: 213-219.
14. Bartel DP, (2009) MicroRNAs: target recognition and regulatory functions. Cell 136: 215-233.
15. Yamada Y, Enokida H, Kojima S, Kawakami K, Chiyomaru T, et al. (2011) MiR-96 and miR-183 detection in urine serve as potential tumor markers of urothelial carcinoma: correlation with stage and grade, and comparison with urinary cytology. Cancer Sci 102: 522-529.
16. Zhou H, Guo JM, Lou YR, Zhang XJ, Zhong FD, et al. (2010) Detection of circulating tumor cells in peripheral blood from patients with gastric cancer using microRNA as a marker. J Mol Med 88: 709-717.
17. Gilad S, Meiri E, Yogev Y, Benjamin S, Lebanony D, et al. (2008) Serum microRNAs are promising novel biomarkers. PLoS One 3: e3148.
18. Schaefer JS, Montufar-Solis D, Vigneswaran N, Klein JR, (2011) Selective upregulation of microRNA expression in peripheral blood leukocytes in IL-10-/- mice precedes expression in the colon. J Immunol 187: 5834-5841.
19. Fassina A, Cappellesso R, Fassan M, (2011) Classification of non-small cell lung carcinoma in transthoracic needle specimens using microRNA expression profiling. Chest 140: 1305-1311.
20. Fassina A, Marino F, Siri M, Zambello R, Ventura L, et al. (2012) The miR-17-92 microRNA cluster: a novel diagnostic tool in large B-cell malignancies. Lab Invest 92: 1574-1582.
21. Catto JW, Alcaraz A, Bjartell AS, De Vere White R, Evans CP, et al. (2011) MicroRNA in prostate, bladder, and kidney cancer: a systematic review. Eur Urol 59: 671-681.
22. Dyrskjot L, Ostenfeld MS, Bramsen JB, Silahtaroglu AN, Lamy P, et al. (2009) Genomic profiling of microRNAs in bladder cancer: miR-129 is associated with poor outcome and promotes cell death in vitro. Cancer Res 69: 4851-4860.
23. Kenney PA, Wszolek MF, Rieger-Christ KM, Neto BS, Gould JJ, et al. (2011) Novel ZEB1 expression in bladder tumorigenesis. BJU Int 107: 656-663.
24. Neely LA, Rieger-Christ KM, Neto BS, Eroshkin A, Garver J, et al. (2010) A microRNA expression ratio defining the invasive phenotype in bladder tumors. Urol Oncol 28: 39-48.
25. Ostenfeld MS, Bramsen JB, Lamy P, Villadsen SB, Fristrup N, et al. (2010) miR-145 induces caspase-dependent and-independent cell death in urothelial cancer cell lines with targeting of an expression signature present in Ta bladder tumors. Oncogene 29: 1073-1084.
26. Wiklund ED, Bramsen JB, Hulf T, Dyrskjot L, Ramanathan R, et al. (2011) Coordinated epigenetic repression of the miR-200 family and miR-205 in invasive bladder cancer. Int J Cancer 128: 1327-1334.
27. Gray W, Kocjan G. (2010) Diagnostic cytopathology. China: Churchill Livingstone Elsevier.
28. Fassina A, Cappellesso R, Guzzardo V, Dalla Via L, Piccolo S, et al. (2012) Epithelial-mesenchymal transition in malignant mesothelioma. Mod Pathol 25: 86-99.
29. Rasmussen R. (2001) Quantification on the LightCycler. In: Meuer S, Wittwer C, Nakagawara K, editors. Rapid Cycle Real-time PCR, Methods and Applications. Heidelberg: Springer Press. 21-34.
30. Magee L, (1990) R2 measures based on Wald and likelihood ratio joint significance tests. Amer Stat. 44: 250-253.
31. Babjuk M, Oosterlinck W, Sylvester R, Kaasinen E, Bohle A, et al. (2011) EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder, the 2011 update. Eur Urol 59: 997-1008.
32. Almallah YZ, Rennie CD, Stone J, Lancashire MJ, (2000) Urinary tract infection and patient satisfaction after flexible cystoscopy and urodynamic evaluation. Urology 56: 37-39.
33. Valadi H, Ekstrom K, Bossios A, Sjostrand M, Lee JJ, et al. (2007) Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol 9: 654-659.
34. Wang G, Chan ES, Kwan BC, Li PK, Yip SK, et al. (2012) Expression of microRNAs in the urine of patients with bladder cancer. Clin Genitourin Cancer 10: 106-113.